Jamaica vs Northern Mariana Islands: The number of people with susceptibility test result for rifampicin
Jamaica
100
in 2021
Northern Mariana Islands
100
in 2021
Jamaica rank
2nd
Northern Mariana Islands rank
2nd
The number of people with susceptibility test result for rifampicin over time
- Jamaica
- Northern Mariana Islands
How they compare
Jamaica currently reports 100 against 100 in Northern Mariana Islands, a difference of 0.
Across all 5 years both countries report, Northern Mariana Islands has been ahead every year.
Jamaica ranks 2nd and Northern Mariana Islands ranks 2nd of 146 countries.
Northern Mariana Islands has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Jamaica | Northern Mariana Islands | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 74.4 | 97.22 | 22.83 | Northern Mariana Islands |
| 2020s | 97.44 | 100 | 2.56 | Northern Mariana Islands |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Jamaica or Northern Mariana Islands?
- Jamaica, at 100 against 100 in Northern Mariana Islands as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Jamaica and Northern Mariana Islands?
- 0, with Jamaica ahead.
- How many years of comparable data are there for Jamaica and Northern Mariana Islands?
- 5 years are reported by both, from 2017 to 2021.
- How do Jamaica and Northern Mariana Islands rank globally for the number of people with susceptibility test result for rifampicin?
- Jamaica ranks 2nd and Northern Mariana Islands ranks 2nd of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.